A few weeks ago (mid-October 2019), the USPTO released an updated (view here) patent subject matter eligibility guidance (PEG) along with new examples related to personalized medicine, therapeutic methods, and pharmaceutical products.   The October update is essentially a clarification of the January 2019 guidance. This update analyzes five areas of the 35 U.S.C. §101 analysis […]